Data shows Nitrosigine almost doubles maximum blood flow compared to arginine HCl and has a blood vessel relaxation effect that is almost five times greater than arginine HCl.
Nutrition 21 LLC (Purchase, NY) has launched Nitrosigine, a patented arginine silicate ingredient that the company says is superior to arginine alone at improving blood flow. FDA has accepted Nitrosigine as a new dietary ingredient (NDI).
The company cites preclinical data showing that Nitrosigine helps enhance blood flow through vasodilation by increasing nitric oxide levels. As such, the ingredient also has applications for sports nutrition and men’s health. For instance, it may enhance blood flow during and after exercise, helping with muscle growth and exercise recovery. The company says data shows Nitrosigine almost doubles maximum blood flow compared to arginine HCl and has a blood vessel relaxation effect that is almost five times greater than arginine HCl. Nitrosigine also aids silicone absorption.
“Nitrosigine provides the benefits of arginine and silicon, with additional benefits from the unique combination,” says James Komorowski, MS, CNS, the company’s vice president of scientific and regulatory affairs.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
PEA may support exercise performance in addition to its anti-inflammatory properties
June 26th 2024The branded palmitoylethanolamide (PEA) ingredient called Levagen+ significantly improved dynamic lower body power, and did not inhibit strength training adaptations unlike NSAIDs or other analgesics.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.